A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.

Bibliographic Details
Main Authors:	McDonagh, Bachmann, Golder, Kleijnen, ter Riet
Format:	Article
Language:	English
Published:	NIHR Journals Library 2000-01-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta4300

Similar Items

A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.
by: Robinson, et al.
Published: (2002-01-01)

Pharmacological Profile of a Novel Platelet Glycoprotein IIb/IIIa Antagonist SM-20302
by: Horisawa, Seiya
Published: (2011)

The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
by: Seo-Hee Kim, et al.
Published: (2021-07-01)

Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice
by: Felipe Maia, et al.
Published: (2009-01-01)

The antiaggregative mechanism of pyridoxal -5''- phosphate (PLP) on the glycoprotein IIb-IIIa( GPIIb-IIIa) and morphology of platelets
by: Wen - Jen Yu, et al.
Published: (1995)

Glycoprotein IIb-IIIa inhibitors – Do we still need them?
by: Vijayakumar Subban, et al.
Published: (2013-05-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
by: Salam Amar M, et al.
Published: (2001-07-01)

Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
by: Kate Lambrechts, et al.
Published: (2018-07-01)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome.
by: Zhi-Jiang Xie, et al.
Published: (2021-01-01)

Concomitant Use of Glycoprotein IIb/IIIa Inhibitor and Streptokinase after Unsuccessful Rescue Angioplasty
by: José Marconi Almeida de Sousa, et al.
Published: (2002-04-01)

Glycoprotein IIb/IIIa and P2Y12 Induction by Oligochitosan Accelerates Platelet Aggregation
by: Mercy Halleluyah Periayah, et al.
Published: (2014-01-01)

A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.
by: Lister-Sharp, et al.
Published: (2000-01-01)

Relationship of Platelet Glycoprotein IIb/IIIa and CD62P With Hypercoagulable State After Oncologic Surgery
by: Xin Zhong, et al.
Published: (2020-11-01)

Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
by: D V Fettser, et al.
Published: (2009-03-01)

EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01)

Effects of two different glycoprotein platelet IIb/IIIa inhibitors and the clinical endpoints in patients with intracranial Pipeline flow diverter implant
by: Qiao Deng, et al.
Published: (2020-12-01)

Markers of endothelial dysfunction in pregnant women with the A2 gene polymorphism of platelet glycoprotein receptors IIb/IIIa
by: A. Y. Muratova, et al.
Published: (2016-02-01)

Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis
by: Xiaolin Zhu MD, et al.
Published: (2020-07-01)

The action mechanism underlying Staphylococcus aureus-induced platelet aggregation: role of platelet glycoprotein IIb/IIIa complex.
by: Shin-Yi, Huang, et al.

Estudo experimental do uso de um antagonista do receptor da glicoproteína IIb/IIIa das placentas na prevenção de tromboses em microanastomoses vasculares An experimental study on the use of an antagonist of the platelet glycoprotein IIb/IIIa receptor in the prevention of thrombosis in vascular microanastomoses
by: Márcio Issamu Oide
Published: (2000-06-01)

Targeted platelet inhibition with a bispecific antibody fragment that binds to platelet glycoprotein IIb/IIIa receptor and tissue factor : prevention of thombosis after angioplasty with a new locally delivered bispecific antibody against tissue factor and platelet glycoprotein IIb/IIIa receptor
by: Hogrefe, Kai
Published: (2005)

Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
by: Peter Kraft, et al.
Published: (2015-01-01)

Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
by: J. P. Howard, et al.
Published: (2014-01-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

Receptor GP IIb/IIIa as an Indicator of Risk in Vascular Events
by: Żanna Fiodorenko-Dumas PhD, et al.
Published: (2019-06-01)

Platelet function in patients with polymorphisms of GP IIb/IIIa and cyclooxygenase
by: McCaslin, James
Published: (2005)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.
by: Fidel Manuel Cáceres Lóriga, et al.
Published: (2001-01-01)

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01)

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
by: Davide Capodanno, et al.
Published: (2019-12-01)

Flow cytometric observations in quantitative and qualitative platlet disorders and in humans recieving infusions of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa
by: Christopoulos, Constantinos
Published: (1992)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-10-01)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-03-01)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
by: Matthew A Silva, et al.
Published: (2006-03-01)

"Woman's face" of unstable angina
by: A. G. Gurchenok, et al.
Published: (2007-08-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
by: Haiyan Xu, et al.
Published: (2017-01-01)

Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study
by: Gardin Julius, et al.
Published: (2006-04-01)

Effect of Salvia miltiorrhiza on cytokines in patients with unstable angina pectoris
by: Shi-Lian Chen, et al.
Published: (2016-04-01)

EXERCISE TESTS IN UNSTABLE ANGINA SUSPECTS
by: M N Alekhin, et al.
Published: (2012-04-01)